OAS1 rs10774671: Understanding Your Genetic Antiviral Response
The rs10774671 variant is a genetic change located in the OAS1 gene that influences how the body produces antiviral proteins. It is primarily studied for its role in modulating the immune system's response to viral infections, including SARS-CoV-2.
What each genotype means
Reduced OAS1 enzymatic activity
This genotype is associated with altered splicing of the OAS1 gene, which may lead to reduced production of the functional p46 isoform. Research suggests this may influence the body's antiviral response, though the clinical impact on infection susceptibility remains a subject of ongoing study. Please discuss any health concerns or questions regarding your immune response with your clinician.
This genotype is common globally, though its frequency varies significantly between populations of African and European ancestry.
Intermediate OAS1 activity profile
Carrying one copy of each allele may result in a mixed expression of OAS1 splicing isoforms. While this genotype is associated with the regulation of antiviral protein activity, the functional consequences are complex and influenced by other genetic and environmental factors. Please discuss any health concerns or questions regarding your immune response with your clinician.
This heterozygous genotype is frequently observed in diverse global populations.
Typical OAS1 activity profile
This genotype is associated with the standard splicing patterns of the OAS1 gene. It is generally considered the baseline for OAS1 enzymatic function in the context of antiviral defense mechanisms. Please discuss any health concerns or questions regarding your immune response with your clinician.
This genotype is common globally, with frequencies that differ notably across various ancestral groups.
What is the rs10774671 Variant?
The rs10774671 variant is a single nucleotide polymorphism (SNP) situated within the OAS1 gene on chromosome 12. Specifically, it acts as a splice-acceptor site variant. In genetics, a splice site is a critical junction that tells the cellular machinery where to cut and join segments of messenger RNA (mRNA) during the process of gene expression. When this site is altered, the cell may produce different versions, or isoforms, of the OAS1 protein. Because these isoforms can have different biological functions, this small change in the DNA sequence can lead to significant differences in how an individual's cells respond to external threats, such as viral pathogens.
The Role of the OAS1 Gene
The OAS1 gene encodes the 2'-5'-oligoadenylate synthetase 1 enzyme. This protein is a key component of the innate immune system, which serves as the body's first line of defense against viruses. When a cell detects the presence of viral genetic material, OAS1 is activated to produce molecules that trigger the degradation of viral RNA, effectively stopping the virus from replicating. Research indicates that the specific isoform produced by the cell depends on the genotype at the rs10774671 site. The 'G' allele is associated with the production of a longer, more active, and membrane-localized form of the enzyme, while the 'A' allele leads to the production of alternative, less active isoforms. This functional difference is why the variant is a subject of intense interest in immunology.
Research and Clinical Associations
Scientific research has linked the rs10774671 variant to variations in susceptibility to severe viral infections, most notably COVID-19. Studies using trans-ancestry fine-mapping have identified this SNP as a likely causal factor in the OAS1 gene cluster that influences disease severity. Individuals carrying the protective 'G' allele tend to produce a more efficient antiviral enzyme, which may help the body clear viral infections more effectively. Conversely, the 'A' allele has been associated with higher risks of severe outcomes in some studies. While the evidence is strong regarding the biological mechanism of splicing, the clinical impact can be complex and influenced by many other genetic and environmental factors. It is important to note that this variant is one of many factors contributing to immune health, and it does not determine an individual's overall health outcome.
Population Frequency and Diversity
The frequency of the rs10774671 alleles varies significantly across different global populations. The protective 'G' allele is found at different frequencies in European and African ancestry groups, and its evolutionary history is linked to both Neanderthal-derived haplotypes and independent ancestral variations. Because the distribution of these alleles is not uniform, researchers emphasize the importance of including diverse populations in genetic studies to fully understand how this variant influences health outcomes globally. Understanding these frequency differences helps scientists better interpret how genetic risk factors for viral susceptibility are distributed across the human population.
What This Information Means for You
Genetic information regarding the rs10774671 variant provides insight into your biological predisposition for antiviral responses, but it is not a diagnostic tool. Having a particular genotype does not guarantee a specific health outcome, as immune function is influenced by a vast array of genetic, lifestyle, and environmental variables. This information should not be used to make medical decisions or to predict your personal risk for any specific disease. If you have concerns about your immune health or susceptibility to infections, the most appropriate course of action is to consult with a qualified healthcare professional. They can provide personalized guidance based on your full medical history and current clinical standards, rather than relying on a single genetic marker.
How common is this variant?
The rs10774671 variant is common globally, though the frequencies of the protective and risk alleles differ significantly between populations of European and African ancestry.
Frequently asked questions
Does my rs10774671 genotype determine if I will get severe COVID-19?
No, this variant is only one of many factors that influence how your immune system responds to a virus. Many other genetic, environmental, and health-related factors play a much larger role in determining the severity of an infection.
Can I change my OAS1 expression through diet or supplements?
There is no established scientific evidence that specific diets or supplements can reliably alter the splicing of the OAS1 gene or compensate for the functional differences caused by this variant. Always consult with a doctor before making changes to your health regimen.
Is rs10774671 the same as rs10774339?
These are distinct identifiers used in genetic databases. While they may be located in the same gene region and sometimes studied together, they refer to different specific locations in the DNA sequence.
Should I get tested for this variant?
Routine testing for this variant is not recommended for the general public. It does not provide actionable clinical information that would change standard medical care or preventative strategies.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10774339?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in OAS1
Splice-site variant in OAS1 affecting isoform expression and susceptibility to viral infections.
Splice-acceptor site polymorphism controlling expression of active OAS1 isoforms and modulating susceptibility to severe viral respiratory infections.